{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:53:12Z","timestamp":1769100792866,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003053","name":"Alberta Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.10.065","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T01:28:43Z","timestamp":1573781323000},"page":"521-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Seeking the optimal schedule for chickenpox vaccination in Canada: Using an agent-based model to explore the impact of dose timing, coverage and waning of immunity on disease outcomes"],"prefix":"10.1016","volume":"38","author":[{"given":"Ellen R.S.","family":"Rafferty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wade","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel D.","family":"Osgood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weicheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Doroshenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.10.065_b0005","unstructured":"Public Health Agency of Canada. Varicella (chickenpox) 2012. http:\/\/www.phac-aspc.gc.ca\/im\/vpd-mev\/varicella-eng.php (accessed September 1, 2019)."},{"key":"10.1016\/j.vaccine.2019.10.065_b0010","unstructured":"European Centre for Disease Prevention and Control. ECDC Guidance: Varicella vaccination in the European Union. Stockholm: 2015."},{"key":"10.1016\/j.vaccine.2019.10.065_b0015","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1097\/INF.0000000000000076","article-title":"Dosing Schedules for Pneumococcal Conjugate Vaccine","volume":"33","author":"Whitney","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.065_b0020","unstructured":"Public Health Agency of Canada. Canada\u2019s provincial and territorial routine (and catch-up) vaccination Routine schedule programs for infants and children this table summarizes the current routine vaccination schedule for infants and children in all provinces and territories across Canad 2018. https:\/\/www.canada.ca\/en\/public-health\/services\/provincial-territorial-immunization-information\/provincial-territorial-routine-vaccination-programs-infants-children.html (accessed January 27, 2019)."},{"key":"10.1016\/j.vaccine.2019.10.065_b0025","doi-asserted-by":"crossref","unstructured":"National Advisory Committee on Immunization. An Advisory Committee Statement: Literature Review on One-Dose and Two-Dose Varicella Vaccination. Canada Commun Dis Rep 2010; 36.","DOI":"10.14745\/ccdr.v36i00a10"},{"key":"10.1016\/j.vaccine.2019.10.065_b0030","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1503\/cmaj.140078","article-title":"Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study","volume":"186","author":"MacDonald","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2019.10.065_b0035","first-page":"1","article-title":"Preventing varicella: recommendations for routine two-dose varicella immunization in children","volume":"16","author":"Salvadori","year":"2011","journal-title":"Paediatr Child Health (Oxford)"},{"key":"10.1016\/j.vaccine.2019.10.065_b0040","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1097\/INF.0b013e31828b7def","article-title":"Primary versus secondary failure after varicella vaccination","volume":"32","author":"Bonanni","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.065_b0045","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1016\/j.vaccine.2014.10.076","article-title":"Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain","volume":"32","author":"Gil-Prieto","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.065_b0050","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3741","article-title":"Global Varicella Vaccine Effectiveness: A Meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2019.10.065_b0055","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.10.065_b0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.065_b0065","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/529043","article-title":"Primary vaccine failure after 1 dose of varicella vaccine in healthy children","volume":"197","author":"Michalik","year":"2008","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.065_b0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jval.2015.01.006","article-title":"Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research\u2014Part 2: Report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force","volume":"18","author":"Marshall","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2019.10.065_b0075","unstructured":"Osgood ND. Representing heterogeneity in complex feedback system modeling: Computational resource and error scaling. Proceedings. In: 22nd Int. Conf. Syst. Dyn. Soc.; 2004, p. 46."},{"key":"10.1016\/j.vaccine.2019.10.065_b0080","unstructured":"Osgood ND. Representing progression and interactions of comorbidities in aggregate and individual-based systems models. Proceedings, 27th Int. Conf. Syst. Dyn. Soc., Albuquerque; 2009. p. 20."},{"key":"10.1016\/j.vaccine.2019.10.065_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7717\/peerj.2337","article-title":"Evaluation of outbreak response immunization in the control of pertussis using agent-based modeling","volume":"4","author":"Doroshenko","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.vaccine.2019.10.065_b0090","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.4161\/hv.25635","article-title":"Provider dismissal policies and clustering of vaccine-hesitant families: an agent-based modeling approach","volume":"9","author":"Buttenheim","year":"2013","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2019.10.065_b0095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1542\/peds.2015-0831","article-title":"Personal belief exemptions to vaccination in California: a spatial analysis","volume":"136","author":"Carrel","year":"2015","journal-title":"Pediatrics"},{"issue":"e5012","key":"10.1016\/j.vaccine.2019.10.065_b0100","first-page":"1","article-title":"Evaluation of the effect of chickenpox vaccination on shingles epidemiology using agent-based modeling","volume":"6","author":"Rafferty","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.vaccine.2019.10.065_b0105","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1098\/rsif.2008.0271","article-title":"The effect of opinion clustering on disease outbreaks","volume":"5","author":"Salath\u00e9","year":"2008","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.vaccine.2019.10.065_b0110","unstructured":"Statistics Canada. Population estimates on July 1st, by age and sex. Gov Canada 2016. https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710000501 (accessed November 6, 2019)."},{"key":"10.1016\/j.vaccine.2019.10.065_b0115","unstructured":"Statistics Canada. Life Tables, Canada, Provinces and Territories 1980\/1982 to 2015\/2017. Gov Canada 2016. https:\/\/www150.statcan.gc.ca\/n1\/pub\/84-537-x\/84-537-x2019001-eng.htm (accessed September 1, 2016)."},{"key":"10.1016\/j.vaccine.2019.10.065_b0120","unstructured":"Statistics Canada. Pregnancy outcomes by age group (Live births). Gov Canada 2008. http:\/\/www.statcan.gc.ca\/tables-tableaux\/sum-som\/l01\/cst01\/hlth65b-eng.htm (accessed July 7, 2017)."},{"key":"10.1016\/j.vaccine.2019.10.065_b0125","doi-asserted-by":"crossref","first-page":"0381","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases","volume":"5","author":"Mossong","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.10.065_b0130","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1016\/j.vaccine.2013.09.018","article-title":"Shingles in Alberta: Before and after publicly funded varicella vaccination","volume":"32","author":"Russell","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.065_b0135","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1016\/j.vaccine.2008.08.016","article-title":"Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program?","volume":"26","author":"Kwong","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.065_b0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2431-12-154","article-title":"Communicating with parents about vaccination: a framework for health professionals","volume":"12","author":"Leask","year":"2012","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.vaccine.2019.10.065_b0145","series-title":"Vaccines","first-page":"837","article-title":"Varicella vaccine","author":"Gershon","year":"2012"},{"key":"10.1016\/j.vaccine.2019.10.065_b0150","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.vaccine.2017.03.054","article-title":"Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection","volume":"35","author":"Duncan","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.065_b0155","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1017\/S0950268811002640","article-title":"The health and economic burden of chickenpox and herpes zoster in Belgium","volume":"140","author":"Bilcke","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.10.065_b0160","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","article-title":"Epidemiology of varicella zoster virus infection in Canada and the United Kingdom","volume":"127","author":"Brisson","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.10.065_b0165","first-page":"1","article-title":"Direct costs attributed to chickenpox and herpes zoster in British Columbia- 1992 to 1998","volume":"25\u201311","author":"Nowgesic","year":"1999","journal-title":"Canada Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2019.10.065_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.104.1.1","article-title":"Cost of chickenpox in Canada: part I. Cost of uncomplicated cases","volume":"104","author":"Law","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2019.10.065_b0175","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1016\/j.vaccine.2013.08.022","article-title":"The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates","volume":"31","author":"Waye","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.065_b0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1371\/journal.pone.0129483","article-title":"Twenty years of medically-attended pediatric varicella and herpes zoster in Ontario, Canada: a population-based study","volume":"10","author":"Wormsbecker","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.10.065_b0185","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/INF.0b013e318260cc4d","article-title":"The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000\u20132008","volume":"31","author":"Tan","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.065_b0190","unstructured":"Alberta Health. Interactive health data application; 2019. http:\/\/www.ahw.gov.ab.ca\/IHDA_Retrieval\/selectSubCategoryParameters.do."},{"key":"10.1016\/j.vaccine.2019.10.065_b0195","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1016\/j.vaccine.2013.07.006","article-title":"Vaccine effects and impact of vaccination programmes in post-licensure studies","volume":"31","author":"Hanquet","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.065_b0200","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.065_b0205","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S0950268809990860","article-title":"Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia","volume":"138","author":"Gao","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.10.065_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1098\/rspb.2016.0054","article-title":"Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination","volume":"283","author":"Betta","year":"2016","journal-title":"Proc R Soc B"},{"key":"10.1016\/j.vaccine.2019.10.065_b0215","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/14760584.2016.1183483","article-title":"Modeling and predicting the long-term effects of various strategies and objectives of varicella- zoster vaccination campaigns","volume":"7","author":"Riche","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.10.065_b0220","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England","volume":"29","author":"Jan van Hoek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.065_b0225","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modelling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"Brisson","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.10.065_b0230","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/j.vaccine.2010.02.079","article-title":"Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster","volume":"28","author":"Brisson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.065_b0235","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1017\/S0950268817001546","article-title":"A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data","volume":"145","author":"Bollaerts","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.10.065_b0240","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1186\/s12889-016-3738-x","article-title":"Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy","volume":"16","author":"Holl","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.10.065_b0245","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.4161\/hv.29576","article-title":"Licensed pertussis vaccines in the United States History and current state","volume":"10","author":"Klein","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.10.065_b0250","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/cid\/cix510","article-title":"Reduced antibody response to infant measles vaccination: effects based on type and timing of the first vaccine dose persist after the second dose","volume":"65","author":"Carazo Perez","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.065_b0255","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s40264-015-0326-4","article-title":"Modelling hospitalisation ratios for febrile convulsions and severe varicella under combined measles, mumps, rubella, and varicella (MMRV\u2014Priorix-TetraTM) compared to separate MMR + V vaccination","volume":"38","author":"Bauchau","year":"2015","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2019.10.065_b0260","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2017.1965","article-title":"Evaluation of combination measles-mumps-rubella-varicella vaccine introduction in Australia","author":"Macartney","year":"2017","journal-title":"JAMA Pediatr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:39:11Z","timestamp":1759401551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19314458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19314458"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seeking the optimal schedule for chickenpox vaccination in Canada: Using an agent-based model to explore the impact of dose timing, coverage and waning of immunity on disease outcomes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}